Early risk stratification using Rubidium-82 positron emission tomography in STEMI patients.


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
04 2019
Historique:
received: 24 02 2017
accepted: 30 06 2017
pubmed: 19 7 2017
medline: 20 8 2020
entrez: 19 7 2017
Statut: ppublish

Résumé

Assessment of infarct size after myocardial infarction is predictive of subsequent morphological changes and clinical outcome. This study aimed to assess subacute post-intervention Rubidium-82 ( STEMI patients undergoing percutaneous coronary intervention were included prospectively. Rest-only 42 patients were included, but only 35 had follow-up CMR and constituted the study population. Absolute blood flow was significantly lower in the infarct-related territory compared to remote myocardium, P < .005. Extent of hypoperfusion correlated with final infarct size, r = 0.58, P < .001, while blood flow correlated with ejection fraction, r = 0.41, P < .05. In linear mixed models, higher subacute absolute blood flow (β = 4.6, confidence interval [3.5; 5.2], P < .001, R Subacute rest-only

Sections du résumé

BACKGROUND
Assessment of infarct size after myocardial infarction is predictive of subsequent morphological changes and clinical outcome. This study aimed to assess subacute post-intervention Rubidium-82 (
METHODS
STEMI patients undergoing percutaneous coronary intervention were included prospectively. Rest-only
RESULTS
42 patients were included, but only 35 had follow-up CMR and constituted the study population. Absolute blood flow was significantly lower in the infarct-related territory compared to remote myocardium, P < .005. Extent of hypoperfusion correlated with final infarct size, r = 0.58, P < .001, while blood flow correlated with ejection fraction, r = 0.41, P < .05. In linear mixed models, higher subacute absolute blood flow (β = 4.6, confidence interval [3.5; 5.2], P < .001, R
CONCLUSIONS
Subacute rest-only

Identifiants

pubmed: 28718077
doi: 10.1007/s12350-017-0993-x
pii: 10.1007/s12350-017-0993-x
pmc: PMC6430746
doi:

Substances chimiques

Contrast Media 0
Rubidium Radioisotopes 0
Rubidium-82 9K730EL8KU
Gadolinium AU0V1LM3JT

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

471-482

Commentaires et corrections

Type : CommentIn

Références

J Electrocardiol. 2016 May-Jun;49(3):278-83
pubmed: 26949016
J Am Coll Cardiol. 1995 Mar 1;25(3):567-73
pubmed: 7860898
Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1765-74
pubmed: 17619189
J Nucl Med. 1999 Mar;40(3):363-70
pubmed: 10086696
Circ Cardiovasc Imaging. 2011 Mar;4(2):139-46
pubmed: 21193690
J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):321-31
pubmed: 21821535
Circulation. 2002 Jan 29;105(4):539-42
pubmed: 11815441
J Nucl Cardiol. 2006 Mar-Apr;13(2):210-9
pubmed: 16580957
Circ Cardiovasc Imaging. 2009 Jul;2(4):299-305
pubmed: 19808610
Eur J Nucl Med Mol Imaging. 2013 Aug;40(8):1148-54
pubmed: 23553081
Am J Cardiol. 1999 Jun 1;83(11):1559-62, A7
pubmed: 10363872
J Am Coll Cardiol. 2014 Mar 25;63(11):1031-45
pubmed: 24486280
Circulation. 1999 Nov 9;100(19):1992-2002
pubmed: 10556226
J Nucl Cardiol. 2018 Jun;25(3):970-981
pubmed: 27743299
Nucl Med Commun. 2010 Jan;31(1):67-74
pubmed: 19823095
Eur Heart J. 2014 Aug 1;35(29):1971-80
pubmed: 24135835
EJNMMI Res. 2016 Dec;6(1):69
pubmed: 27650281
J Am Coll Cardiol. 2007 Jul 10;50(2):149-56
pubmed: 17616299
J Am Coll Cardiol. 1997 Dec;30(7):1633-40
pubmed: 9385887
Eur J Nucl Med Mol Imaging. 2004 Jul;31(7):969-74
pubmed: 15004727
Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1065-9
pubmed: 22410839
J Nucl Cardiol. 2017 Apr;24(2):657-667
pubmed: 26843199
J Am Coll Cardiol. 2016 Apr 12;67(14):1674-83
pubmed: 27056772
Circulation. 1995 Aug 1;92(3):334-41
pubmed: 7634446
Eur Heart J Cardiovasc Imaging. 2013 Apr;14(4):387-95
pubmed: 23178864
Am J Cardiol. 2007 Apr 15;99(8):1109-14
pubmed: 17437737
J Nucl Med. 2010 Feb;51(2):198-203
pubmed: 20080895
Ann Nucl Med. 2013 Feb;27(2):112-22
pubmed: 23065422
Circulation. 1980 Dec;62(6):1266-74
pubmed: 7438362
Basic Res Cardiol. 1995 Mar-Apr;90(2):103-11
pubmed: 7646414

Auteurs

Adam Ali Ghotbi (AA)

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark. adamghotbi@gmail.com.

Philip Hasbak (P)

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.

Lars Nepper-Christensen (L)

Department of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.

Jacob Lønborg (J)

Department of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.

Kiril Atharovski (K)

Department of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.

Thomas Christensen (T)

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.

Lene Holmvang (L)

Department of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.

Thomas Engstrøm (T)

Department of Cardiology, The Heart Center, Rigshospitalet University of Copenhagen, Copenhagen, Denmark.

Rasmus Sejersten Ripa (RS)

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.

Andreas Kjær (A)

Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet University of Copenhagen, Blegdamsvej 9, 2100, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH